Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 15/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 12/20 | 0.46 |
| ▸ | TNIK | Q9UKE5 | 2/20 | 0.37 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869672 | 0.89 | CHRNA7 (0.56) | CHRNA7KCNH2 | |
| SCHEMBL30869646 | 0.89 | CHRNA7 (0.56) | CHRNA7KCNH2 | |
| SCHEMBL30869658 | 0.87 | CHRNA7 (0.47) | CHRNA7KCNH2TNIKPIK3C3 | |
| SCHEMBL30869429 | 0.87 | CHRNA7 (0.55) | CHRNA7KCNH2TNIK | |
| SCHEMBL30869683 | 0.86 | GSK3B (0.42) | CHRNA7KCNH2TNIKPIK3C3PDE10A | |
| SCHEMBL30869436 | 0.85 | TNIK (0.36) | CHRNA7KCNH2TNIKPIK3C3PDE10A | |
| SCHEMBL30869447 | 0.83 | CHRNA7 (0.57) | CHRNA7KCNH2TNIK | |
| SCHEMBL30869491 | 0.83 | CHRNA7 (0.57) | CHRNA7KCNH2TNIK | |
| SCHEMBL30869548 | 0.79 | BRAF (0.42) | CHRNA7KCNH2 | |
| SCHEMBL30869473 | 0.78 | CHRNA7 (0.49) | CHRNA7KCNH2TNIK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | DNM1, DNM1L, DNM2 | CHRNA7 1850/4885KCNH2 851/4885TNIK 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.